Seikagaku News

List of conversion stocks (part 2) [List of stocks converting with Parabolic Signals]

○ List of stocks converted to Sell Market Code Stock Name Closing Price SAR Tokyo Main Board <1663> K&O Energy 3200 3375 <1852> Asanuma Corp 726739 <1911> Sumitomo Forestry 46534825 <2002> Nisshin flour G 17751780 <2127> Japan M&A 631661 <2229> Calbee 29012965 <2737> Tomen Deva 61806300 <2753> Amiyaki 162416

Fisco JapanMar 27 18:35 ET

Biochemistry has fallen, shunned by the downward revision of financial estimates.

Biochemical Industries <4548.T>, a pharmaceutical manufacturer strong in carbohydrate Chemicals, fell for the first time in three days. It began with a sell indication and briefly dropped to 775 yen, 25 yen lower than the previous day. After the market closed on the 26th, a downward revision of the financial estimates for the fiscal year ending in March 2025 was announced. The projected consolidated operating profit for the full year was lowered from 3.95 billion yen to 1.8 billion yen (4.2 times higher than the previous fiscal year). The decrease in royalties and the increase in research and development expenses had an impact. Provided by Wealth Advisor Co.

Kabushiki ShimbunMar 26 21:03 ET

Seikagaku To Go Ex-Dividend On March 28th, 2025 With 15 JPY Dividend Per Share

March 27th (Japan Standard Time) - $Seikagaku(4548.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 15 JPY dividend per share. The ex-dividend

Moomoo NewsMar 26 21:00 ET

List of cloud penetration stocks [Ichimoku Kinko Hyo - List of cloud penetration stocks]

○ List of stocks that have broken through the cloud market Code Stock Name End Price Leading Span A Leading Span B Tokyo Main Board <1429> Japan Aqua 764 747 762.5 <1968> Taihei Electric 4980 4893.75 4950 <2207> Meito Sangyo 2042 2035.25 2020 <2220> Kameda Seika 4020 3953.75 4010 <2359> Core 1884 1867.75 1856.5

Fisco JapanMar 26 18:54 ET

＜Today's individual materials＞ Veru Inc, Iore, Resonac, and Dainippon Ink and Chemicals, etc. (Announcement on the 26th)

▽Liberata <4935.T> has obtained a patent in Japan for the "clothing cooling mist" developed in collaboration with Taffrey International, related to the "cooling agent composition". ▽Iore <2334.T> has started a new business in Cryptos financial services and an Artificial Intelligence (AI) Datacenter business. ▽Resonac <4004.T> expects a significant decrease in operating profit for the fiscal year ending December 2025 (IFRS). ▽Dainippon Seika <4116.T> has projected a net profit for the consolidated fiscal year ending March 2025.

Kabushiki ShimbunMar 26 18:53 ET

Resona Holdings turned profitable with an operating profit of 89 billion yen for the fiscal year ending December 2024, while the Financial Estimates for December 2025 predict a 45.0% decrease to 49 billion yen.

Resonac HD <4004> announced its performance for the fiscal year ending December 2024, with revenue increasing by 7.4% year-on-year to 1 trillion 391.4 billion 80 million yen, and an operating profit of 89 billion 36 million yen (compared to a loss of 9.4 billion 7 million yen in the previous period). For the fiscal year ending December 2025, revenue is projected to increase by 2.2% year-on-year to 1 trillion 422 billion yen, while operating profit is planned to decrease by 45% to 49 billion yen. 【Positive Evaluation】 <4644> Imagineer Correction | 【Hold】 <4116> Dainippon Screen.

Fisco JapanMar 26 16:53 ET

Key points of attention for PTS on the 26th = Imagineer, Basis, Yamaha, ETC.

▽ Imaginia <4644.T> has raised its consolidated net profit Financial Estimates for the fiscal year ending March 2025, and has also increased its Dividends Financial Estimates. ▽ Basis <4068.T> has introduced a shareholder incentive program. ▽ Yamaha <7951.T> has announced its stock buyback. ▽ Oncoress B <4588.T> has received a patent grant for a patent related to the administration method of 'tumor lytic virus OBP-301'. ▽ Isin <143A.T> is set to make human resources consulting firm Repser a subsidiary. ▽ Quest <2332.T> is developing a business application.

Kabushiki ShimbunMar 26 03:27 ET

Seikagaku: Notice regarding revisions to the full-year consolidated earnings forecast for the fiscal year ending March 31, 2025

JPXMar 26 03:00 ET · Announcements

Express News | [Change Report] Invesco Asset Management reported a decrease in shareholding of Biochemical Industry (4548.JP) to 5.8%.

Moomoo NewsMar 21 02:48 ET

March 13 [Today's Investment Strategy]

[FISCO Selected Stocks] 【Material Stocks】 Alpico Holdings <297A> 247 yen (3/12) engaged in distribution, transportation, and tourism businesses based in Nagano. It has announced that a commemorative dividend of 2 yen will be implemented at the end of the March 2025 fiscal year. The year-end dividend (annual dividend) will be 5 yen (including the commemorative dividend of 2 yen). The previous Financial Estimates were 3 yen, and for the previous term, it was also 3 yen. The company aims to enhance its financial health by strengthening the management foundation of the entire group and improving corporate value, thereby maintaining stable Dividends for its Shareholders. 【Emerging Market

Fisco JapanMar 12 20:05 ET

Focus on ANYCOLOR and Bestela, while Double A and others are weak.

In the US stock market on the 12th, the Dow Jones Industrial Average fell by $82.55 to 41,350.93, the Nasdaq Composite Index rose by 212.35 points to 17,648.45, and the Chicago Nikkei 225 Futures were up 315 yen from the Osaka daytime to 37,105 yen. The exchange rate was 1 dollar = 148.10-20 yen. In today's Tokyo market, gumi <3903> turned its operating profit for the cumulative third quarter into a profit of 0.299 billion yen, up from a deficit of 3.029 billion yen in the same period last year, with operating profit increasing by 51.3% from the previous period and 3.2 times this period.

Fisco JapanMar 12 19:15 ET

Afternoon session [Active stocks and traded stocks]

*Bio-Chemicals <4548> 776 +12 A phase 3 clinical trial for osteoarthritis treatment product 'Gel-One' has commenced in Japan. The resistance to further gains is significant. *Riken Technos <4220> 1025 +2625 The upward revision of the financial estimates for the fiscal year ending March 2025 and the announcement of a Share Buyback program of 3.8% of outstanding stocks. *SCSK <9719> 3776 +13 Domestic securities have upgraded their rating due to expected synergy effects from the integration. The resistance to further gains is significant. *GladCube <9561> 1168 -92 The global...

Fisco JapanFeb 25 02:10 ET

February 25 [Today's Investment Strategy]

[Fisco Selected Stocks]【Material Stocks】Escrow Agent Japan <6093> 160 yen (2/21) Engaged in real estate-related business such as escrow (third-party deposit), contract services, human resource dispatch, and auctions. While promoting the digital transformation of registration-related operations associated with real estate transactions, obtained a Business model patent for the cloud play in the progress management system, "EAJ Platform System (EPS)," and the business processes utilizing it.

Fisco JapanFeb 24 19:02 ET

Focus on biochemistry and Star Micronics HD, while V-Cube and high-pressure gas seem to be soft.

In the Tokyo market during the three-day weekend, on the 21st, the Dow Jones Industrial Average fell by $748.63, while yesterday, the 24th, it rose by $33.19 to $43,461.21. The Nasdaq Composite Index dropped by 438.36 points on the 21st and fell by 237.08 points yesterday to 19,286.93. Yesterday, the Chicago Nikkei 225 Futures were down 770 yen from Osaka daytime, at 38,020 yen. The exchange rate is 1 dollar = 149.60-70 yen. In today's Tokyo market, a special profit (subsidy income) of 5.09 is expected for the fourth quarter of the fiscal year ending February 2025.

Fisco JapanFeb 24 18:15 ET

Biochemistry --- A pharmaceutical company with strengths in "carbohydrate science" has obtained approval for hernia-related Pharmaceuticals from U.S. authorities, which will be a future catalyst.

Bikakukagaku Industry (4548) is a pharmaceutical company that has been established for over 70 years. Specializing in the scientific field of "Carbohydrate Science," which involves complex carbohydrates and sugar chains, the company has produced numerous Pharmaceuticals and Medical Devices. The distinctive feature of their Business model is that they narrow down their research and development targets and diseases, engaging in niche research and development activities that utilize their technology and know-how related to carbohydrate science. Additionally, the company does not have a pharmaceutical sales division and develops a Business model that forms sales partnerships with pharmaceutical companies that have strengths in various product areas.

Fisco JapanFeb 21 03:06 ET

MITSUBISHI ESTATE, 3Q operating profit increased by 32.5% to 194.4 billion yen.

MITSUBISHI ESTATE <8802> announced its financial results for the third quarter of the fiscal year ending March 2025, with operating revenue increasing by 13.1% year-on-year to 1 trillion 47.9 billion 19 million yen, and operating profit rising by 32.5% to 194.4 billion 78 million yen. Both income and capital gains are progressing smoothly towards the company's full-year financial estimates. In Japan, the stable Market Overview is being leveraged, leading to an increase in capital gains. Additionally, the Brokerage business is performing well. [Positive Evaluation] <8802> MITSUBISHI ESTATE Q4| <7740> TAMRON

Fisco JapanFeb 9 16:12 ET

Seikagaku: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2025 [Japanese GAAP] (Consolidated)

JPXFeb 7 02:00 ET · Announcements

Daifuku construction, KFC, Duskin, and Shin Nihon Seiyaku (7th) (1332-5976)

※ The above Calendar is only a plan and may be subject to change due to company circumstances. --------------------------------------- February 7 (Friday) <1332> Nissui <1429> Aqua Japan <143A> Ishin <1450> Tanaka Construction Industry <151A> Dai <167A> Ryosan Ryoho <1717> Meihou Facility <1721> Comsys

Fisco JapanFeb 6 16:30 ET

List of conversion stocks (Part 1) [Parabolic Signal Conversion Stocks]

○List of stocks undergoing Buy conversion in the market Code Stock Name Closing Price SAR Tokyo Main Board <1301> Kiyokyo 4115 3945 <1332> Nissui 900873 <1377> Sakata Seed 34703370 <1726> Br. HD 346330 <1802> Obayashi Corporation 21012025 <1808> Haseko Corporation 20491980 <1820> Nishimatsu Construction 52485066 <1887> Japan National.

Fisco JapanDec 29, 2024 19:28 ET

Ferring Announces U.S. FDA Advisory Committee Meeting for SI-6603 (Condoliase), An Investigational Treatment in Lumbar Disc Herniation

BusinesswireDec 2, 2024 09:05 ET